| Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer BR McDonald, T Contente-Cuomo, SJ Sammut, A Odenheimer-Bergman, ... Science translational medicine 11 (504), eaax7392, 2019 | 252 | 2019 |
| Evaluation of pre-analytical factors affecting plasma DNA analysis H Markus, T Contente-Cuomo, M Farooq, WS Liang, MJ Borad, ... Scientific reports 8 (1), 7375, 2018 | 136 | 2018 |
| Abstract P4-01-21: Multiplexed targeted digital sequencing of circulating tumor DNA to detect minimal residual disease in early and locally advanced breast cancer BR McDonald, T Contente-Cuomo, SJ Sammut, B Ernst, ... Cancer Research 79 (4_Supplement), P4-01-21-P4-01-21, 2019 | 52 | 2019 |
| Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer KK Budhraja, BR McDonald, MD Stephens, T Contente-Cuomo, H Markus, ... Science translational medicine 15 (678), eabm6863, 2023 | 21 | 2023 |
| Noninvasive diagnostics for early detection of lung cancer: challenges and potential with a focus on changes in DNA methylation M Farooq, JG Herman Cancer Epidemiology, Biomarkers & Prevention 29 (12), 2416-2422, 2020 | 20 | 2020 |
| Personalized circulating tumor dna analysis to detect residual disease after neoadjuvant therapy in breast cancer. Sci Transl Med 11: eaax7392 BR McDonald, T Contente-Cuomo, SJ Sammut, A Odenheimer-Bergman, ... | 10 | 2019 |
| Anaerobic respiration: In vitro efficacy of Nitazoxanide against mitochondriate Acanthamoeba castellanii of the T4 genotype Y Aqeel, R Siddiqui, M Farooq, NA Khan Experimental parasitology 157, 170-176, 2015 | 10 | 2015 |
| Analysis of fragment ends in plasma DNA from patients with cancer KK Budhraja, BR McDonald, MD Stephens, T Contente-Cuomo, H Markus, ... medRxiv, 2021.04. 23.21255935, 2021 | 6 | 2021 |
| Blood-based multi-cancer detection: A state-of-the-art update M Farooq, E Leevan, J Ahmed, B Ko, S Shin, A De Souza, N Takebe Current Problems in Cancer 48, 101059, 2024 | 4 | 2024 |
| Detection of residual disease after neoadjuvant therapy in breast cancer using personalized circulating tumor DNA analysis BR McDonald, T Contente-Cuomo, SJ Sammut, A Odenheimer-Bergman, ... bioRxiv, 425470, 2018 | 4 | 2018 |
| Detection of copy number aberrations in cholangiocarcinoma using shallow whole genome sequencing of plasma DNA. M Farooq, JB Egan, B McDonald, H Markus, T Contente-Cuomo, ... Journal of Clinical Oncology 36 (4_suppl), 293-293, 2018 | 4 | 2018 |
| Evaluation of pre-analytical factors affecting plasma DNA analysis. Sci Rep. 2018; 8: 7375 H Markus, T Contente-Cuomo, M Farooq, WS Liang, MJ Borad, ... | 4 | |
| Trends in disparities in clinical trial accrual: An analysis of National Cancer Institute (NCI)-sponsored early phase clinical trials over the last 22 years M Farooq, E Sharon, N Takebe, AF Best, S Finnigan CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 32 (12), 2023 | | 2023 |
| Abstract B036: Trends in disparities in clinical trial accrual: An analysis of National Cancer Institute (NCI)-sponsored early phase clinical trials over the last 22 years M Farooq, E Sharon, N Takebe, AF Best, S Finnigan Cancer Epidemiology, Biomarkers & Prevention 32 (12_Supplement), B036-B036, 2023 | | 2023 |
| Detection of FGFR fusions in intrahepatic cholangiocarcinoma using targeted RNA sequencing. M Farooq, H Markus, B McDonald, JB Egan, T Contente-Cuomo, ... Journal of Clinical Oncology 39 (15_suppl), e16185-e16185, 2021 | | 2021 |
| Personalized monitoring of treatment response using Targeted Digital Sequencing of circulating tumor DNA BR McDonald, T Contente-Cuomo, SJ Sammut, MD Stephens, ... CLINICAL CANCER RESEARCH 26 (11), 61-61, 2020 | | 2020 |
| Abstract A51: Personalized monitoring of treatment response using Targeted Digital Sequencing of circulating tumor DNA BR McDonald, T Contente-Cuomo, SJ Sammut, MD Stephens, ... Clinical Cancer Research 26 (11_Supplement), A51-A51, 2020 | | 2020 |
| Circulating Tumor DNA Analysis and Opportunities for Personalized Cancer Medicine M Farooq, M Murtaza Companion and Complementary Diagnostics, 229-242, 2019 | | 2019 |
